Company Profile

EDAP Technomed S.A. (NASDAQ: EDAP)
4:00 PM EST, 02/21/18
Last: $2.50 Change: +0.00 %Change: +0.00% Volume: 35,039
Detailed Quote
Open: $2.50   Volume: 35,039
High: $2.54   Yield(%) n/a
Low: $2.49   P/E Ratio (ttm): n/a
Dividend ($): n/a   Market Cap ($): 72.49M
EPS ($) n/a   Shares Out: 29.00M
M = Million B = Billion
Price Performance
% Price Change (last 4 weeks): -7.06
% Price Change (last 13 weeks): -19.09
% Price Change (last 26 weeks): -8.76
% Price Change (last 52 weeks): -16.39
% Price Change (year to date): -12.59
Management Effectiveness
Return on Equity (%): 13.78
Return on Assets (%): 9.30
Return on Invested Capital (%): n/a
Profitability
Gross Profit Margin (%): 44.25
Net Profit Margin (%): -0.22
Operating Profit Margin (%): -2.29
Price & Volume
50-day Moving Average: $2.70
200-day Moving Average: $2.93
Avg. Daily Vol. (last 50 days): 61,661
Avg. Daily Vol. (last 200 days): 74,737
52-wk high: $3.85
52-wk low: $2.25
Bid: $2.50
Ask: $2.54
Company Information
EDAP TMS SA develops, produces and markets minimally invasive medical devices for urological diseases. HIFU treatment is shown to be a minimally invasive and effective treatment option with a low occurrence of side effects. Ablatherm-HIFU is generally recommended for patients with localized prostate cancer who are not candidates for surgery or who prefer an alternative option, or for patients who failed radiotherapy treatment, Ablatherm-HIFU is approved and commercialized in Europe as a treatment for prostate cancer and is currently under regulatory review in the U.S. In March 2013, the company introduced a new innovative HIFU device, the Focal One dedicated to focal therapy of prostate cancer. The company was founded on December 3, 1979 and is headquartered in Vaulx-en-Velin, France.
EDAP Technomed S.A.
Parc d'Activit├ęs la Poudrette-Lamart 4/6, rue du Dauphine
Vaulx-en-Velin RA 69120

Phone: 33.4.72.15.31.5
Fax: 33.4.72.15.31.5
http://www.edap-tms.com
Per Share Data
Earnings (1year) ($): 0.00
Annual Dividend ($): 0.00
Current P/E Ratio (ttm): n/a
Book Value ($): 0.00
Cash Flow ($): -0.03
Valuation Ratios
Price/Earnings (x): 16.18
Price/Sales (x): 1.81
Price/Book (x): 2.50
Price/Cash Flow (x): n/a
Financial Strength
Quick Ratio (x): n/a
Current Ratio (x): 2.00
LT Debt/Equity (x): 0.00
Total Debt/Equity (x): n/a



Quotes displayed with 15 minutes delay. Market data provided by ICE Data Services ICE Limitations. Powered and implemented by FactSet. Legal Statement. News provided by MT Newswires, a Division of MidnightTrader, Inc. Hemscott equity data provided by Morningstar, Inc. Earnings Calendar and Events Data provided by Wall Street Horizon. © 2017 Wall Street Horizon, Inc.